September 28, 2023 ∙ jessica-sacher
Clinical trials
Phage therapy
Biotech news
Instill Science
A place to discuss science, share work, and find mentors and collaborators
Instill Science / post-KhAZowiE
Loading ...
No comments yet. Be the first to comment!
The first patient in Armata Pharmaceuticals’ newest trial has been treated. This is part of the Phase 2a portion of their diSArm study, which evaluates the potential treatment of S. aureus bacteremia.